We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Healthpeak's Q1 FFO Meets Estimates, Same-Store NOI Rises
Read MoreHide Full Article
Healthpeak Properties, Inc. (DOC - Free Report) ) reported first-quarter 2025 funds from operations (FFO) as adjusted per share of 46 cents, meeting the Zacks Consensus Estimate. This compares to the FFO of 45 cents reported in the prior year.
Results reflect better-than-anticipated revenues. Growth in total merger-combined same-store cash (adjusted) net operating income (NOI) was witnessed across the portfolio. However, higher interest expenses affected the results to some extent.
This healthcare real estate investment trust (REIT) generated revenues of $702.9 million, outpacing the Zacks Consensus Estimate of $691.9 million. The figure climbed 15.9% year over year.
Behind DOC’s Earnings Headlines
In the first quarter, Healthpeak reported 7% year-over-year growth in the total merger-combined same-store cash (adjusted) NOI.
It witnessed 5% and 7.7% year-over-year growth in the total merger-combined same-store cash (adjusted) NOI for its outpatient medical and lab segments, respectively. The CCRC segment reported growth of 15.9%.
During the reported quarter, Healthpeak executed lab new and renewal leases totaling 276,000 square feet, with retention at 88% and +5% cash-releasing spreads on renewals.
For the outpatient medical portfolio, new and renewal leases aggregated 973,000 square feet, with retention at 86% and +4% cash-releasing spreads on renewals. However, interest expenses jumped 19.4% year over year to $72.7 million.
DOC’s Balance Sheet
Healthpeak exited the first quarter with cash and cash equivalents of $70.6 million, down from $119.8 million as of Dec. 31, 2024. Its net debt to adjusted EBITDAre was 5.2X as of March 31, 2025.
Beginning the current year through April 24, the company has repurchased 5.1 million shares at a weighted average price of $18.50 for a total amount of $94 million.
DOC’s 2025 Outlook
The company has reaffirmed its previous guidance. The company expects its 2025 FFO as adjusted per share to be between $1.81 and $1.87. The Zacks Consensus Estimate is presently pegged at $1.85, which is within expectations.
The total merger-combined same-store cash (adjusted) NOI growth is estimated to be in the range of 3-4%.
Healthpeak currently carries a Zacks Rank #3 (Hold).
Healthpeak Properties, Inc. Price, Consensus and EPS Surprise
We now look forward to the earnings releases of other healthcare REITs, such as Welltower, Inc. (WELL - Free Report) and Ventas, Inc. (VTR - Free Report) , slated to report on April 28 and April 30, respectively. (See the Zacks Earnings Calendar to stay ahead of market-making news.)
The Zacks Consensus Estimate for Ventas’ first-quarter 2025 FFO per share stands at 82 cents, indicating a 5.1% rise year over year. VTR currently has a Zacks Rank #2.
Note: Anything related to earnings presented in this write-up represents funds from operations (FFO), a widely used metric to gauge the performance of REITs.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Healthpeak's Q1 FFO Meets Estimates, Same-Store NOI Rises
Healthpeak Properties, Inc. (DOC - Free Report) ) reported first-quarter 2025 funds from operations (FFO) as adjusted per share of 46 cents, meeting the Zacks Consensus Estimate. This compares to the FFO of 45 cents reported in the prior year.
Results reflect better-than-anticipated revenues. Growth in total merger-combined same-store cash (adjusted) net operating income (NOI) was witnessed across the portfolio. However, higher interest expenses affected the results to some extent.
This healthcare real estate investment trust (REIT) generated revenues of $702.9 million, outpacing the Zacks Consensus Estimate of $691.9 million. The figure climbed 15.9% year over year.
Behind DOC’s Earnings Headlines
In the first quarter, Healthpeak reported 7% year-over-year growth in the total merger-combined same-store cash (adjusted) NOI.
It witnessed 5% and 7.7% year-over-year growth in the total merger-combined same-store cash (adjusted) NOI for its outpatient medical and lab segments, respectively. The CCRC segment reported growth of 15.9%.
During the reported quarter, Healthpeak executed lab new and renewal leases totaling 276,000 square feet, with retention at 88% and +5% cash-releasing spreads on renewals.
For the outpatient medical portfolio, new and renewal leases aggregated 973,000 square feet, with retention at 86% and +4% cash-releasing spreads on renewals. However, interest expenses jumped 19.4% year over year to $72.7 million.
DOC’s Balance Sheet
Healthpeak exited the first quarter with cash and cash equivalents of $70.6 million, down from $119.8 million as of Dec. 31, 2024. Its net debt to adjusted EBITDAre was 5.2X as of March 31, 2025.
Beginning the current year through April 24, the company has repurchased 5.1 million shares at a weighted average price of $18.50 for a total amount of $94 million.
DOC’s 2025 Outlook
The company has reaffirmed its previous guidance. The company expects its 2025 FFO as adjusted per share to be between $1.81 and $1.87. The Zacks Consensus Estimate is presently pegged at $1.85, which is within expectations.
The total merger-combined same-store cash (adjusted) NOI growth is estimated to be in the range of 3-4%.
Healthpeak currently carries a Zacks Rank #3 (Hold).
Healthpeak Properties, Inc. Price, Consensus and EPS Surprise
Healthpeak Properties, Inc. price-consensus-eps-surprise-chart | Healthpeak Properties, Inc. Quote
Upcoming Earnings Releases
We now look forward to the earnings releases of other healthcare REITs, such as Welltower, Inc. (WELL - Free Report) and Ventas, Inc. (VTR - Free Report) , slated to report on April 28 and April 30, respectively. (See the Zacks Earnings Calendar to stay ahead of market-making news.)
The Zacks Consensus Estimate for Welltower’s first-quarter 2025 FFO per share is pegged at $1.15, implying a 13.7% year-over-year increase. WELL currently carries a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
The Zacks Consensus Estimate for Ventas’ first-quarter 2025 FFO per share stands at 82 cents, indicating a 5.1% rise year over year. VTR currently has a Zacks Rank #2.
Note: Anything related to earnings presented in this write-up represents funds from operations (FFO), a widely used metric to gauge the performance of REITs.